Raymond James Rates Humana (HUM) Outperform, $520 Price Target
Raymond James raises its rating on Humana Inc. to Outperform with a new price target of $520, a 24.29% upside from the current price.
Reviewed by automated data checks against the source data. How we make and check alerts
Raymond James rated Humana Inc. ($HUM) "Outperform" with a $520 price target on October 12, 2026.
Since the rating, $HUM is down 4.7% to date (from the $433.50 close on Oct 12, 2026).
HUM
Humana Inc.
Key Points
- Raymond James upgraded Humana Inc. to an Outperform rating on October 12, 2026, with a price target of $520.
- Raymond James's $520 price target implies 24.29% upside from Humana Inc.'s ($HUM) current $418.36 share price.
- Humana's shares recently traded around $418.36, which is about 19.5% below the new analyst target.
- The company's next earnings report is scheduled for November 6, 2026.
Get $HUM trade alerts by text
We text you when insiders, Congress or big funds trade $HUM. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Humana Inc. alert may contain errors. Disclosures
Raymond James raised its rating on Humana Inc. (NYSE: HUM) to Outperform on October 12, 2026, setting a new price target of $520. This upgrade comes as the company continues to show strong growth in the healthcare sector, with a revenue growth rate of 26.2% year-over-year.
Other Institutional Activity in Humana Inc.
Several other institutional investors have also adjusted their positions in Humana. Dodge & Cox Inc. reduced its stake by 440,438 shares, now holding 10,940,380 shares worth about $4.5 billion. BlackRock Inc. added 218,270 shares to its holdings, bringing its total to 10,417,803 shares valued at approximately $4.3 billion. Vanguard Capital Management LLC slightly increased its position by 4,703 shares, totaling 7,843,620 shares valued at around $3.2 billion. Vanguard Portfolio Management LLC and State Street Corporation also made minor adjustments to their holdings.
Humana Inc. Stock Down 2.1%
As of October 16, 2026, Humana's shares were recently trading at $418.36, which is above the 50-day moving average by about 6.5% and above the 200-day moving average by approximately 39.3%. However, the stock is about 19.5% below the analyst target and 8.4% below its 52-week high of $456.50.
$HUM price target
Humana Inc. daily closes and this analyst's $520 target. Not advice.
Recent Earnings
Humana reported trailing twelve-month revenue of $145.68 billion and earnings per share (EPS) of $10.88. The next earnings report is expected on November 6, 2026, which could further influence analyst opinions and investor sentiment.
Insider Buying and Selling at Humana Inc.
On February 23, 2026, Officer Sanjay K. Shetty bought 810 shares at an average price of $185.20, totaling approximately $150,016. This transaction occurred before the recent analyst upgrades and reflects confidence in the company's future prospects.
Analysts Set New Price Targets
On October 12, 2026, Oppenheimer maintained its Outperform rating on Humana with a target of $525, while UBS also maintained a Neutral rating but raised its target to $495 from $405. Truist Securities kept its Hold rating and adjusted its price target to $475 from $415. Barclays maintained an Overweight rating, increasing its target to $582 from $515.
About Humana Inc.
Humana Inc. provides medical and specialty insurance products across the United States. The company operates in two main segments: Insurance and CenterWell. Its recent upgrade by Raymond James highlights the positive outlook for Humana in a growing healthcare market.
Bottom Line
Investors will be watching for Humana's next earnings report on November 6, 2026, to gauge the company's performance and how it aligns with the optimistic outlook from analysts. With the recent upgrades, including Raymond James' new target of $520, the stock's movement will be closely monitored in the coming weeks.
Related Filing Alerts
Source: Raymond James's rating change on $HUM (Oct 12, 2026). Written by software, not financial advice. How we make alerts